Sep 182 min readNewsPlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery diseaseProject evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay...
May 142 min readNewsPlaqueTec and the Babraham Institute collaborate on early phase target discovery and developmentCampus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by...
Apr 302 min readNewsPlaqueTec closes $8 million equity financingThe financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support...
Jan 232 min readNewsPlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery bloodCollaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary...
Dec 14, 20231 min readNewsProfiling plaque to guide treatment of coronary artery diseasePublished in Cardiovascular News, Dr Stephen Hoole, Chief Investigator of our BIOPATTERN trial and Consultant Cardiologist at Royal...
Nov 29, 20233 min readNewsPlaqueTec recruits first ten patients in BIOPATTERN trialPlaqueTec receives the UK’s MHRA approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.